Table 1.
CIE L*, a*, b* mean standard deviation values of Groups 1-3, in all experimental periods
| baseline | 1st week | 1st month | 3rd month | ||
| (CIE) L* parameter | |||||
| Groups | n | L0 | L1 | L2 | L3 |
| MTA Fillapex | 15 | 84.95(3.14) | 85.36(2.54) | 84.35(3.10) | 84.91(2.61) |
| Roth 811 | 15 | 84.21(1.98) | 81.89(1.18) | 79.38(1.82) | 79.28(1.71) |
| Negative control | 15 | 84.55(2.22) | 84.77(2.26) | 84.48(2.34) | 84.55(2.17) |
| baseline | 1st week | 1st month | 3rd month | ||
| (CIE) a* parameter | |||||
| Groups | n | a0 | a1 | a2 | a3 |
| MTA Fillapex | 15 | 0.15(0.68) | 0.57(0.67) | 0.77(0.68) | 1.19(0.65) |
| Roth 811 | 15 | 0.01(0.79) | 2.03(0.82) | 2.71(1.00) | 3.34(1.05) |
| Negative control | 15 | 0.42(0.74) | 0.39(0.66) | 0.38(0.73) | 0.41(0.73) |
| baseline | 1st week | 1st month | 3rd month | ||
| (CIE) b* parameter | |||||
| Groups | n | b0 | b1 | b2 | b3 |
| MTA Fillapex | 15 | 21.60(2.82) | 23.36(2.21) | 22.64(2.74) | 23.89(2.35) |
| Roth 811 | 15 | 21.26(2.33) | 25.67(2.36) | 24.76(2.72) | 25.28(2.89) |
| Negative control | 15 | 20.62(3.11) | 20.33(2.89) | 20.49(2.94) | 20.57(3.07) |
Within-group comparisons: a statistically significant differences when compared to t0, b when compared to t1, c when compared to t2, d when compared to t3
Between-group comparisons: a statistically significant differences when compared to Fillapex, B when compared to Roth 811